| Literature DB >> 28208607 |
Liuhong Zhang1, Shah Iram Niaz2, Dilfaraz Khan3, Zhen Wang4, Yonghong Zhu5, Haiyun Zhou6, Yongcheng Lin7, Jing Li8,9, Lan Liu10,11.
Abstract
Two new sesquiterpenes, microsphaeropsisin B (1) and C (2), and two new de-O-methyllasiodiplodins, (3R, 7R)-7-hydroxy-de-O-methyllasiodiplodin (4) and (3R)-5-oxo-de-O-methyllasiodiplodin (5), together with one new natural product (6) and twelve known compounds (3, 7-17), were isolated from the co-cultivation of mangrove endophytic fungus Trichoderma sp. 307 and aquatic pathogenic bacterium Acinetobacter johnsonii B2. Their structures, including absolute configurations, were elucidated by extensive analysis of spectroscopic data, electronic circular dichroism, Mo₂(AcO)₄-induced circular dichroism, and comparison with reported data. All of the isolated compounds were tested for their α-glucosidase inhibitory activity and cytotoxicity. New compounds 4 and 5 exhibited potent α-glucosidase inhibitory activity with IC50 values of 25.8 and 54.6 µM, respectively, which were more potent than the positive control (acarbose, IC50 = 703.8 µM). The good results of the tested bioactivity allowed us to explore α-glucosidase inhibitors in lasiodiplodins.Entities:
Keywords: co-cultivation; lasiodiplodin; mangrove endophytic fungus; sesquiterpene; α-glucosidase inhibitor
Mesh:
Substances:
Year: 2017 PMID: 28208607 PMCID: PMC5334615 DOI: 10.3390/md15020035
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1HPLC profiles of secondary metabolites from Acinetobacter johnsonii B2 (a), Trichoderma sp. 307 (b) and co-cultivation of two microorganisms (c) from up to down (detection wavelength: 254 nm).
Figure 2Structures of compounds 1–17.
1H (400 MHz) and 13C (100 MHz) NMR data of 1 and 2.
| Position | 1 a | 2 a | ||
|---|---|---|---|---|
| δC | δH ( | δC | δH ( | |
| 1 | 146.6 | 7.04 (d, | 146.1 | 7.01 (d, |
| 2 | 126.3 | 5.84 (d, | 128.4 | 5.93 (d, |
| 3 | 206.8 | 203.4 | ||
| 4 | 55.0 | 2.24 (q, | 54.4 | 2.24 (q, |
| 5 | 39.9 | 40.4 | ||
| 6a | 34.6 | 1.79 (d, | 38.9 | 1.87 (d, |
| 6b | 1.44 (d, | 1.51 (d, | ||
| 7 | 77.8 | 77.6 | ||
| 8 | 100.5 | 100.3 | ||
| 9 | 135.3 | 6.10 (s) | 132.2 | 5.94 (s) |
| 10 | 139.4 | 142.4 | ||
| 11 | 43.9 | 2.58 (ddq, | 43.9 | 2.54 (ddq, |
| 12a | 71.8 | 4.07 (dd, | 71.6 | 4.04 (dd, |
| 12b | 3.34 (dd, | 3.31 (dd, | ||
| 13 | 9.2 | 1.01 (d, | 9.2 | 1.01 (d, |
| 14 | 14.8 | 0.95 (d, | 7.5 | 1.08 (d, |
| 15 | 28.0 | 1.35 (s) | 20.9 | 1.16 (s) |
a Measured in MeOH-d4.
Figure 3Key HMBC (black arrows), 1H-1H COSY (bold lines), and NOESY (double arrows) correlations of compounds 1 and 2.
Figure 4Mo2(AcO)4-induced CD spectra of compounds 1 and 2.
Figure 5Calculated and experimental ECD spectra of compounds 1 and 2.
Figure 6Key HMBC (black arrows) and 1H-1H COSY (bold lines) correlations of compounds 4, 5, and 6.
Figure 7Calculated and experimental ECD spectra of compounds 4, 5, and 6.
1H (400 MHz) and 13C (100 MHz) NMR data of 4–6.
| Position | 4 a | 5 b | 6 b | |||
|---|---|---|---|---|---|---|
| δC | δH ( | δC | δH ( | δC | δH ( | |
| 1 | 172.0 | 171.0 | 171.8 | |||
| 3 | 73.7 | 5.37 (m) | 69.3 | 5.69 (ddq, | 74.9 | 5.28 (ddq, |
| 4 | 31.4 | 1.94 (m) | 46.1 | 3.31 (dd, | 31.7 | 1.94 (dd, |
| 1.65 (m) | 2.39 (dd, | 1.84 (dd, | ||||
| 5 | 30.2 | 1.74 (m) | 210.7 | 19.2 | 2.08 (m) | |
| 1.28 (m) | 1.76 (m) | |||||
| 6 | 32.5 | 2.12 (m) | 46.1 | 2.61 (m) | 38.6 | 2.64 (m) |
| 1.83 (m) | 2.30 (m) | 2.55 (m) | ||||
| 7 | 68.0 | 4.27 (m) | 21.8 | 2.01 (m) | 211.4 | |
| 1.86 (m) | ||||||
| 8 | 24.1 | 1.92 (m) | 29.9 | 1.48 (m) | 42.1 | 2.44 (m) |
| 1.67 (m) | 1.25 (m) | 2.35 (m) | ||||
| 9 | 31.1 | 2.06 (m) | 30.3 | 1.66 (m) | 28.9 | 2.20 (m) |
| 1.76 (m) | 1.57 (m) | 1.75 (m) | ||||
| 10 | 33.7 | 3.22 (m) | 36.8 | 3.45 (m) | 33.6 | 3.14 (m) |
| 2.59 (m) | 2.11 (m) | 2.61 (m) | ||||
| 11 | 148.3 | 149.0 | 148.0 | |||
| 12 | 111.9 | 6.74 (d, | 111.1 | 6.17 (d, | 110.8 | 6.24 (d, |
| 13 | 163.9 | 160.5 | 160.5 | |||
| 14 | 102.3 | 6.84 (d, | 101.8 | 6.26 (d, | 102.0 | 6.30 (d, |
| 15 | 164.9 | 166.1 | 165.8 | |||
| 16 | 107.6 | 104.8 | 106.0 | |||
| 17 | 18.2 | 1.38 (d, | 19.9 | 1.44 (d, | 19.6 | 1.35 (d, |
| 15-OH | 12.42 (s) | 11.97 (s) | 12.05(s) | |||
a Measured in pyridine-d5; b Measured in CDCl3.
α-Glucosidase inhibitory activities a.
| Compounds | IC50 (µM) | Compounds | IC50 (µM) |
|---|---|---|---|
| >200 | 60.3 ± 0.7 | ||
| 188.7 ± 1.2 | >200 | ||
| >200 | >200 | ||
| 25.8 ± 0.2 | >200 | ||
| 54.6 ± 0.5 | 198.1 ± 1.5 | ||
| 178.5 ± 1.1 | ˃200 | ||
| 176.8 ± 1.4 | 101.3 ± 0.9 | ||
| 64.2 ± 0.5 | 105.7 ± 1.0 | ||
| 48.9 ± 0.4 | Acarbose b | 703.8 ± 2.2 |
a IC50 values are shown as mean ± SD from two independent experiments; b Positive control.